During 2026 Constant’s research focused on how different forms of life co/exist and circulate in the midst of damage and toxicity.
SPLINT
From 2023 to 2027, Constant develops a program around what we call SPLINT, "Speculative, Libre, Intersectional Technologies". More on SPLINT in Constant mission.
/B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item> /B_item>







































































